Proteomics

Dataset Information

0

Adaptive responses of Pseudomonas aeruginosa to treatment with antibiotics


ABSTRACT: Circumventing or overwhelming the bacterial adaptation capabilities is key to combatting multidrug-resistant pathogens like Pseudomonas aeruginosa. In an effort to understand the physiological response of P. aeruginosa to clinically relevant antibiotics, we investigated the proteome after exposure to ciprofloxacin, levofloxacin, rifampicin, gentamicin, tobramycin, azithromycin, tigecycline, polymyxin B, colistin, ceftazidime, meropenem, and piperacillin/tazobactam. We further investigated the response to CHIR-90, which represents a promising class of lipopolysaccharide biosynthesis inhibitors currently under evaluation. Radioactive pulse-labeling of newly synthesized proteins followed by 2D-PAGE was used to monitor the acute response of P. aeruginosa to antibiotic treatment. Marker proteins were excised from non-radioactive gels and identified by mass spectrometry. The proteomic profiles provide insights into the cellular defense strategies for each antibiotic. A mathematical comparison of these response profiles based on upregulated marker proteins revealed similarities of responses to antibiotics acting on the same target area.

INSTRUMENT(S): Synapt MS

ORGANISM(S): Pseudomonas Aeruginosa Pao1

SUBMITTER: Christoph Senges  

LAB HEAD: Julia E. Bandow

PROVIDER: PXD029948 | Pride | 2021-11-29

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
170315_Cipro1.raw.zip Raw
170315_Cipro10.raw.zip Raw
170315_Cipro11.raw.zip Raw
170315_Cipro12.raw.zip Raw
170315_Cipro13.raw.zip Raw
Items per page:
1 - 5 of 211

Similar Datasets

2022-08-12 | PXD022879 | Pride
2020-10-01 | PXD011640 | Pride
2016-03-14 | PXD003439 | Pride
2020-10-01 | PXD017640 | Pride
2021-11-17 | GSE188801 | GEO
2021-06-08 | GSE173073 | GEO
2024-02-07 | GSE249862 | GEO
2021-03-09 | PXD012622 | Pride
2009-12-19 | E-MEXP-2396 | biostudies-arrayexpress
2024-09-02 | BIOMD0000000425 | BioModels